Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Clinical trial NCT05577312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05577312
- Sponsor
- Bioray Laboratories
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-02
- Primary completion
- 2026-10-20
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.